SIX1 and breast carcinoma: This is consistent with a study on 262 breast cancer tissues showing that breast cancer patients with higher SIX1 protein level had remarkably lower 5-year OS rate than those with low SIX1 expression.[14] Furthermore, patients with higher SIX1 mRNA level were also found to exhibit obviously worse RFS.